Literature DB >> 9711443

Management of the hypertensive patient who smokes.

H Pardell1, R Tresserras, E Saltó, P Armario, R Hernández.   

Abstract

Smoking and arterial hypertension are highly prevalent at the community level. While the coexistence of both risk factors is less frequent, the potentiation of cardiovascular risk when both are present makes the association highly relevant in terms of a preventive approach. There are many interrelationships between smoking and high blood pressure at the clinical, epidemiological and pathophysiological levels. Those demonstrable links compel us to review the usual explanation of the influence of smoking on blood pressure. Pharmacological treatment of the hypertensive patient who smokes must be adapted to the patient's risk profile, using the most efficacious antihypertensive agents. With the exception of nonselective beta-blockers, all the available antihypertensive drugs can be prescribed. Minimal intervention and nicotine replacement constitute the most well tested interventions in helping smokers to quit their habit. Nicotine replacement is currently a well tolerated intervention, even in patients with cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9711443     DOI: 10.2165/00003495-199856020-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  87 in total

1.  Effects of calcium channel blockers on cardiovascular responses to smoking in normotensive and hypertensive smokers.

Authors:  R Fogari; A Zoppi; G D Malamani; L Corradi
Journal:  Int J Clin Pharmacol Res       Date:  1992

2.  Cadmium accumulation im man: influence of smoking, occupation, alcoholic habit and disease.

Authors:  G P Lewis; W J Jusko; L L Coughlin
Journal:  J Chronic Dis       Date:  1972-12

3.  Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study.

Authors:  J Wikstrand; I Warnold; G Olsson; J Tuomilehto; D Elmfeldt; G Berglund
Journal:  JAMA       Date:  1988-04-01       Impact factor: 56.272

4.  Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.

Authors:  J D Morrow; B Frei; A W Longmire; J M Gaziano; S M Lynch; Y Shyr; W E Strauss; J A Oates; L J Roberts
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

5.  Long-term smoking impairs platelet-derived nitric oxide release.

Authors:  K Ichiki; H Ikeda; N Haramaki; T Ueno; T Imaizumi
Journal:  Circulation       Date:  1996-12-15       Impact factor: 29.690

6.  The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease.

Authors:  A M Joseph; S M Norman; L H Ferry; A V Prochazka; E C Westman; B G Steele; S E Sherman; M Cleveland; D O Antonuccio; D O Antonnucio; N Hartman; P G McGovern
Journal:  N Engl J Med       Date:  1996-12-12       Impact factor: 91.245

7.  How effective is nicotine replacement therapy in helping people to stop smoking?

Authors:  J L Tang; M Law; N Wald
Journal:  BMJ       Date:  1994-01-01

Review 8.  Smoking and hypertension as predictors of cardiovascular risk in population studies.

Authors:  W B Kannel; M Higgins
Journal:  J Hypertens Suppl       Date:  1990-09

9.  Elevated endothelin-1 levels after cigarette smoking.

Authors:  T Haak; E Jungmann; C Raab; K H Usadel
Journal:  Metabolism       Date:  1994-03       Impact factor: 8.694

10.  Effect of coffee and cigarette smoking on the blood pressure of untreated and diuretic-treated hypertensive patients.

Authors:  S Freestone; L E Ramsay
Journal:  Am J Med       Date:  1982-09       Impact factor: 4.965

View more
  2 in total

Review 1.  [Pathogenesis and epidemiology of arterial hypertension].

Authors:  H Pardell; P Armario; R Hernández
Journal:  Drugs       Date:  1998       Impact factor: 9.546

2.  High blood pressure and exposure to dust from gold mine dumps among the elderly in South Africa: A cross-sectional study.

Authors:  Vusumuzi Nkosi; Joyce Shirinde; Funzani Rathogwa-Takalani; Kuku Voyi
Journal:  Public Health Pract (Oxf)       Date:  2021-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.